{"bundle_type":"pith_open_graph_bundle","bundle_version":"1.0","pith_number":"pith:2016:O3QYTOKCZEYUNQJERLGUZK7JJG","short_pith_number":"pith:O3QYTOKC","canonical_record":{"source":{"id":"1604.05082","kind":"arxiv","version":1},"metadata":{"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"q-bio.TO","submitted_at":"2016-04-18T10:56:59Z","cross_cats_sorted":[],"title_canon_sha256":"1eb1f434826c68c144e3e9a39460b0926334a1d5f3fb9c58575ca82aabd6e422","abstract_canon_sha256":"789e5e4cea63b39215fe527f6adc37efe0298656ee94be79af2db82c2f45944c"},"schema_version":"1.0"},"canonical_sha256":"76e189b942c93146c1248acd4cabe949833a4d06aafbd99f6c3334d1b08dd4fb","source":{"kind":"arxiv","id":"1604.05082","version":1},"source_aliases":[{"alias_kind":"arxiv","alias_value":"1604.05082","created_at":"2026-05-18T01:16:55Z"},{"alias_kind":"arxiv_version","alias_value":"1604.05082v1","created_at":"2026-05-18T01:16:55Z"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.1604.05082","created_at":"2026-05-18T01:16:55Z"},{"alias_kind":"pith_short_12","alias_value":"O3QYTOKCZEYU","created_at":"2026-05-18T12:30:36Z"},{"alias_kind":"pith_short_16","alias_value":"O3QYTOKCZEYUNQJE","created_at":"2026-05-18T12:30:36Z"},{"alias_kind":"pith_short_8","alias_value":"O3QYTOKC","created_at":"2026-05-18T12:30:36Z"}],"events":[{"event_type":"record_created","subject_pith_number":"pith:2016:O3QYTOKCZEYUNQJERLGUZK7JJG","target":"record","payload":{"canonical_record":{"source":{"id":"1604.05082","kind":"arxiv","version":1},"metadata":{"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"q-bio.TO","submitted_at":"2016-04-18T10:56:59Z","cross_cats_sorted":[],"title_canon_sha256":"1eb1f434826c68c144e3e9a39460b0926334a1d5f3fb9c58575ca82aabd6e422","abstract_canon_sha256":"789e5e4cea63b39215fe527f6adc37efe0298656ee94be79af2db82c2f45944c"},"schema_version":"1.0"},"canonical_sha256":"76e189b942c93146c1248acd4cabe949833a4d06aafbd99f6c3334d1b08dd4fb","receipt":{"kind":"pith_receipt","key_id":"pith-v1-2026-05","algorithm":"ed25519","signed_at":"2026-05-18T01:16:55.780133Z","signature_b64":"ZiFnxDKcXFEIbMjKu0EVDc7nS1qQmBAkQz+Tsjog/4Q2ehyUHeCXD8NRCOc60Y7relgLeDPL94h9aLzFQlg3Ag==","signed_message":"canonical_sha256_bytes","builder_version":"pith-number-builder-2026-05-17-v1","receipt_version":"0.3","canonical_sha256":"76e189b942c93146c1248acd4cabe949833a4d06aafbd99f6c3334d1b08dd4fb","last_reissued_at":"2026-05-18T01:16:55.779474Z","signature_status":"signed_v1","first_computed_at":"2026-05-18T01:16:55.779474Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"source_kind":"arxiv","source_id":"1604.05082","source_version":1,"attestation_state":"computed"},"signer":{"signer_id":"pith.science","signer_type":"pith_registry","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"created_at":"2026-05-18T01:16:55Z","supersedes":[],"prev_event":null,"signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"J3eyGJMeHb0ss/iivwPqtKo0Zke7mBfoKRmnRXRCZig2/ce2H1EXRVV0PMh0BPvPCt42LhqlYduWT+1WP1/IBQ==","signed_message":"open_graph_event_sha256_bytes","signed_at":"2026-05-26T21:23:43.474342Z"},"content_sha256":"777bd2a51ecebcd11cb53d5cbdf69e624aa8ef3a405e60c26cdba3d1dc335126","schema_version":"1.0","event_id":"sha256:777bd2a51ecebcd11cb53d5cbdf69e624aa8ef3a405e60c26cdba3d1dc335126"},{"event_type":"graph_snapshot","subject_pith_number":"pith:2016:O3QYTOKCZEYUNQJERLGUZK7JJG","target":"graph","payload":{"graph_snapshot":{"paper":{"title":"Why one-size-fits-all vaso-modulatory interventions fail to control glioma invasion: in silico insights","license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","headline":"","cross_cats":[],"primary_cat":"q-bio.TO","authors_text":"A. Deutsch, A. Kohn-Luque, F. Feuerhake, H. Hatzikirou, J. C. L. Alfonso, T. Stylianopoulos","submitted_at":"2016-04-18T10:56:59Z","abstract_excerpt":"There is an ongoing debate on the therapeutic potential of vaso-modulatory interventions against glioma invasion. Prominent vasculature-targeting therapies involve functional tumour-associated blood vessel deterioration and normalisation. The former aims at tumour infarction and nutrient deprivation medi- ated by vascular targeting agents that induce occlusion/collapse of tumour blood vessels. In contrast, the therapeutic intention of normalising the abnormal structure and function of tumour vascular net- works, e.g. via alleviating stress-induced vaso-occlusion, is to improve chemo-, immuno- "},"claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"1604.05082","kind":"arxiv","version":1},"verdict":{"id":null,"model_set":{},"created_at":null,"strongest_claim":"","one_line_summary":"","pipeline_version":null,"weakest_assumption":"","pith_extraction_headline":""},"references":{"count":0,"sample":[],"resolved_work":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","internal_anchors":0},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"author_claims":{"count":0,"strong_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"builder_version":"pith-number-builder-2026-05-17-v1"},"verdict_id":null},"signer":{"signer_id":"pith.science","signer_type":"pith_registry","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"created_at":"2026-05-18T01:16:55Z","supersedes":[],"prev_event":null,"signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"auftkx2xVhigURTTGA7VACitxP92JKjtMI9qBBQu++NNfi+cIEbWpzJ/SL40UaIkkk50ZNIoOtupaYqhAIfYDw==","signed_message":"open_graph_event_sha256_bytes","signed_at":"2026-05-26T21:23:43.474796Z"},"content_sha256":"bd3df21f8c22e0a6bd4f4736f3396e59720e50540d2664cf0f7ba619134702fc","schema_version":"1.0","event_id":"sha256:bd3df21f8c22e0a6bd4f4736f3396e59720e50540d2664cf0f7ba619134702fc"}],"timestamp_proofs":[],"mirror_hints":[{"mirror_type":"https","name":"Pith Resolver","base_url":"https://pith.science","bundle_url":"https://pith.science/pith/O3QYTOKCZEYUNQJERLGUZK7JJG/bundle.json","state_url":"https://pith.science/pith/O3QYTOKCZEYUNQJERLGUZK7JJG/state.json","well_known_bundle_url":"https://pith.science/.well-known/pith/O3QYTOKCZEYUNQJERLGUZK7JJG/bundle.json","status":"primary"}],"public_keys":[{"key_id":"pith-v1-2026-05","algorithm":"ed25519","format":"raw","public_key_b64":"stVStoiQhXFxp4s2pdzPNoqVNBMojDU/fJ2db5S3CbM=","public_key_hex":"b2d552b68890857171a78b36a5dccf368a953413288c353f7c9d9d6f94b709b3","fingerprint_sha256_b32_first128bits":"RVFV5Z2OI2J3ZUO7ERDEBCYNKS","fingerprint_sha256_hex":"8d4b5ee74e4693bcd1df2446408b0d54","rotates_at":null,"url":"https://pith.science/pith-signing-key.json","notes":"Pith uses this Ed25519 key to sign canonical record SHA-256 digests. Verify with: ed25519_verify(public_key, message=canonical_sha256_bytes, signature=base64decode(signature_b64))."}],"merge_version":"pith-open-graph-merge-v1","built_at":"2026-05-26T21:23:43Z","links":{"resolver":"https://pith.science/pith/O3QYTOKCZEYUNQJERLGUZK7JJG","bundle":"https://pith.science/pith/O3QYTOKCZEYUNQJERLGUZK7JJG/bundle.json","state":"https://pith.science/pith/O3QYTOKCZEYUNQJERLGUZK7JJG/state.json","well_known_bundle":"https://pith.science/.well-known/pith/O3QYTOKCZEYUNQJERLGUZK7JJG/bundle.json"},"state":{"state_type":"pith_open_graph_state","state_version":"1.0","pith_number":"pith:2016:O3QYTOKCZEYUNQJERLGUZK7JJG","merge_version":"pith-open-graph-merge-v1","event_count":2,"valid_event_count":2,"invalid_event_count":0,"equivocation_count":0,"current":{"canonical_record":{"metadata":{"abstract_canon_sha256":"789e5e4cea63b39215fe527f6adc37efe0298656ee94be79af2db82c2f45944c","cross_cats_sorted":[],"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"q-bio.TO","submitted_at":"2016-04-18T10:56:59Z","title_canon_sha256":"1eb1f434826c68c144e3e9a39460b0926334a1d5f3fb9c58575ca82aabd6e422"},"schema_version":"1.0","source":{"id":"1604.05082","kind":"arxiv","version":1}},"source_aliases":[{"alias_kind":"arxiv","alias_value":"1604.05082","created_at":"2026-05-18T01:16:55Z"},{"alias_kind":"arxiv_version","alias_value":"1604.05082v1","created_at":"2026-05-18T01:16:55Z"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.1604.05082","created_at":"2026-05-18T01:16:55Z"},{"alias_kind":"pith_short_12","alias_value":"O3QYTOKCZEYU","created_at":"2026-05-18T12:30:36Z"},{"alias_kind":"pith_short_16","alias_value":"O3QYTOKCZEYUNQJE","created_at":"2026-05-18T12:30:36Z"},{"alias_kind":"pith_short_8","alias_value":"O3QYTOKC","created_at":"2026-05-18T12:30:36Z"}],"graph_snapshots":[{"event_id":"sha256:bd3df21f8c22e0a6bd4f4736f3396e59720e50540d2664cf0f7ba619134702fc","target":"graph","created_at":"2026-05-18T01:16:55Z","signer":{"key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signer_id":"pith.science","signer_type":"pith_registry"},"payload":{"graph_snapshot":{"author_claims":{"count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","strong_count":0},"builder_version":"pith-number-builder-2026-05-17-v1","claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"paper":{"abstract_excerpt":"There is an ongoing debate on the therapeutic potential of vaso-modulatory interventions against glioma invasion. Prominent vasculature-targeting therapies involve functional tumour-associated blood vessel deterioration and normalisation. The former aims at tumour infarction and nutrient deprivation medi- ated by vascular targeting agents that induce occlusion/collapse of tumour blood vessels. In contrast, the therapeutic intention of normalising the abnormal structure and function of tumour vascular net- works, e.g. via alleviating stress-induced vaso-occlusion, is to improve chemo-, immuno- ","authors_text":"A. Deutsch, A. Kohn-Luque, F. Feuerhake, H. Hatzikirou, J. C. L. Alfonso, T. Stylianopoulos","cross_cats":[],"headline":"","license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"q-bio.TO","submitted_at":"2016-04-18T10:56:59Z","title":"Why one-size-fits-all vaso-modulatory interventions fail to control glioma invasion: in silico insights"},"references":{"count":0,"internal_anchors":0,"resolved_work":0,"sample":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"1604.05082","kind":"arxiv","version":1},"verdict":{"created_at":null,"id":null,"model_set":{},"one_line_summary":"","pipeline_version":null,"pith_extraction_headline":"","strongest_claim":"","weakest_assumption":""}},"verdict_id":null}}],"author_attestations":[],"timestamp_anchors":[],"storage_attestations":[],"citation_signatures":[],"replication_records":[],"corrections":[],"mirror_hints":[],"record_created":{"event_id":"sha256:777bd2a51ecebcd11cb53d5cbdf69e624aa8ef3a405e60c26cdba3d1dc335126","target":"record","created_at":"2026-05-18T01:16:55Z","signer":{"key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signer_id":"pith.science","signer_type":"pith_registry"},"payload":{"attestation_state":"computed","canonical_record":{"metadata":{"abstract_canon_sha256":"789e5e4cea63b39215fe527f6adc37efe0298656ee94be79af2db82c2f45944c","cross_cats_sorted":[],"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"q-bio.TO","submitted_at":"2016-04-18T10:56:59Z","title_canon_sha256":"1eb1f434826c68c144e3e9a39460b0926334a1d5f3fb9c58575ca82aabd6e422"},"schema_version":"1.0","source":{"id":"1604.05082","kind":"arxiv","version":1}},"canonical_sha256":"76e189b942c93146c1248acd4cabe949833a4d06aafbd99f6c3334d1b08dd4fb","receipt":{"algorithm":"ed25519","builder_version":"pith-number-builder-2026-05-17-v1","canonical_sha256":"76e189b942c93146c1248acd4cabe949833a4d06aafbd99f6c3334d1b08dd4fb","first_computed_at":"2026-05-18T01:16:55.779474Z","key_id":"pith-v1-2026-05","kind":"pith_receipt","last_reissued_at":"2026-05-18T01:16:55.779474Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","receipt_version":"0.3","signature_b64":"ZiFnxDKcXFEIbMjKu0EVDc7nS1qQmBAkQz+Tsjog/4Q2ehyUHeCXD8NRCOc60Y7relgLeDPL94h9aLzFQlg3Ag==","signature_status":"signed_v1","signed_at":"2026-05-18T01:16:55.780133Z","signed_message":"canonical_sha256_bytes"},"source_id":"1604.05082","source_kind":"arxiv","source_version":1}}},"equivocations":[],"invalid_events":[],"applied_event_ids":["sha256:777bd2a51ecebcd11cb53d5cbdf69e624aa8ef3a405e60c26cdba3d1dc335126","sha256:bd3df21f8c22e0a6bd4f4736f3396e59720e50540d2664cf0f7ba619134702fc"],"state_sha256":"428aab51b340fce3c40fbdaf7931a43ab4e2f38fa4e6aba1e2dcf0021361ec1e"},"bundle_signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"35A9wgNfi/1EeQ525OgPq5O5NAtkPiudP/Sxolp9DvmFD4MvsSbDl/CzdU6GPjx6jAWL2nsjasFICCCLPhgVBQ==","signed_message":"bundle_sha256_bytes","signed_at":"2026-05-26T21:23:43.477202Z","bundle_sha256":"2084cae7ccc20adfe664fdc1d4df56ee287db7ff068d7af7d5b18c225861a287"}}